Your browser doesn't support javascript.
loading
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing.
Chen, Xin-Zhu; Guo, Rong; Zhao, Cong; Xu, Jing; Song, Hang; Yu, Hua; Pilarsky, Christian; Nainu, Firzan; Li, Jing-Quan; Zhou, Xin-Ke; Zhang, Jian-Ye.
Afiliação
  • Chen XZ; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Guo R; The First Affiliated Hospital, Hainan Medical University, Haikou, China.
  • Zhao C; State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Xu J; Department of Cellular and Molecular Biology, Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Beijing, China.
  • Song H; Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
  • Yu H; Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
  • Pilarsky C; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
  • Nainu F; Department of Surgery, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Li JQ; Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia.
  • Zhou XK; The First Affiliated Hospital, Hainan Medical University, Haikou, China.
  • Zhang JY; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Front Pharmacol ; 13: 939090, 2022.
Article em En | MEDLINE | ID: mdl-35935840
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China